Tempest Therapeutics, Inc. (TPST) Financials
TPST Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 24.0 million | 25.2 million |
2023-06-30 | 30.7 million | 25.7 million |
2023-03-31 | 37.3 million | 26.4 million |
2022-12-31 | 46.1 million | 28.0 million |
TPST Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.5 million | 563000 |
2023-06-30 | -6.5 million | 440000 |
2023-03-31 | -8.3 million | 446000 |
2022-12-31 | -6.8 million | 428000 |
TPST Net Income
No data available :(
TPST Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.1 million | - | 10.5 million |
2023-06-30 | 17.6 million | - | 11.0 million |
2023-03-31 | 22.9 million | - | 11.2 million |
2022-12-31 | 31.2 million | - | 11.7 million |
TPST Shares Outstanding
TPST Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 4.2 million | 2.4 million | - |
2023-06-30 | 117000 | 4.4 million | 3.1 million | - |
2023-03-31 | 46000 | 4.7 million | 2.9 million | - |
2022-12-31 | 356000 | 5.8 million | 3.1 million | - |
TPST Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 510000 |
2023-06-30 | - | 497000 |
2023-03-31 | - | 557000 |
2022-12-31 | - | 539000 |
TPST
Price: $3.69
52 week price:
Earnings Per Share: -1.91 USD
P/E Ratio: -1.90
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5600
Market Capitalization: 79.7 million